[시장보고서]세계의 니페디핀 시장 : 투여형별, 적응증별, 유통 채널별, 지역별

세계의 니페디핀 시장 : 투여형별, 적응증별, 유통 채널별, 지역별

Nifedipine Medication Market, By Dosage Form, By Indication, By Distribution Channel, By Geography

상품코드 : 1741201

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 니페디핀 시장은 2025년 12억 5,670만 달러로 추정되고, 2032년까지 23억 5,700만 달러에 이를 것으로 예측되고, 2025년부터 2032년까지 연평균 성장률(CAGR) 9.4%를 보일 것으로 예측됩니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	12억 5,670만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR	9.40%	2032년 금액 예측	23억 5,700만 달러

니페디핀은 칼슘 채널 차단제로 고혈압이나 협심증에 의한 흉통의 치료에 사용됩니다. 니페디핀은 심장이나 동맥의 근육세포에 있는 칼슘 채널을 차단하는 것으로 작용합니다. 이것에 의해 혈관이 확대되어, 혈압이 저하해, 심장에 대한 부담이 경감됩니다.

시장 역학

고혈압과 심혈관 질환을 앓고 있는 사람들 증가와 고령화 인구 증가는 예측 기간 동안 세계 니페디핀 약물 시장의 성장을 가속할 것으로 예상되는 주요 요인입니다.

게다가, 시장 진출기업은 니페디핀의 신제품 출시에 이르렀으며, 이는 예측 기간동안 세계 니페디핀 시장의 성장을 증가시킬 것으로 예측됩니다. 예를 들어, 2019년 9월 18일, 제네릭 의약품 개발 기업인 AVET Pharmaceuticals는 니페디핀 소프트젤 캡슐을 출시했습니다. 이 제품은 10mg과 20mg의 효능으로 쉽게 구할 수 있습니다. 이 제품은 칼슘 채널 차단제 프로카르디아의 AB 랭크의 제네릭 의약품이며, 아벳사의 견고한 제네릭 경구 고형 제제 포트폴리오에 가입하고 있습니다.

그러나 특허 만료, 규제 문제, 부작용, 대체 치료의 가용성, 치료 패러다임 전환, 가격 압력 등은 예측 기간 동안 세계 니페디핀 약물 시장의 성장을 방해할 것으로 예측됩니다.

본 조사의 주요 특징

본 보고서에서는 세계의 니페디핀 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모와 복합연간 성장률(CAGR)을 제공합니다.
또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시와 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개변수를 기반으로 세계 니페디핀 시장의 주요 기업을 프로파일링합니다.
이 보고서로부터 통찰은 마케팅 담당자나 기업의 경영진이, 장래의 제품의 발매, 유형의 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 한다고 생각됩니다.
세계의 니페디핀 시장 보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 애널리스트 등, 이 산업의 다양한 이해 관계자에 대응하고 있습니다.
이해관계자는 세계의 니페디핀 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

소개
북미
- 미국
- 캐나다
라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN 국가
- 기타 아시아태평양
중동
- GCC 국가
- 이스라엘
- 기타 중동
아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카

제9장 경쟁 구도

기업 프로파일
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd
- Mylan NV
- Sanofi SA
- Johnson & Johnson
- GlaxoSmithKline plc.
- Lupin Limited
- Sun Pharmaceutical Industries Ltd.
- Sandoz International GmbH(Novartis의 부문)
- Dr. Reddy's Laboratories Ltd.
- Torrent Pharmaceuticals Ltd.
- Apotex Inc.

제10장 섹션

참고문헌
조사 방법
출판사에 대해

JHS

영문 목차

영문목차

Nifedipine Medication Market is estimated to be valued at USD 1,256.7 Mn in 2025 and is expected to reach USD 2,357.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1,256.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.40%	2032 Value Projection:	USD 2,357.0 Mn

Nifedipine is a calcium channel blocker medication which is used for treating high blood pressure and chest pain caused by angina. Calcium channel blockers work by relaxing muscles in artery walls and increasing the supply of blood and oxygen to the heart. Nifedipine was first approved for medical use in 1983. It works by blocking calcium channels in heart and artery muscle cells. This helps blood vessels dilate, thus lowering blood pressure and reducing strain on the heart. It comes in both short-acting and long-acting tablet formulations and has proven effective for millions worldwide in controlling blood pressure and reducing chest pain.

Market Dynamics:

A growing number of people suffering from hypertension and cardiovascular illnesses and increasing aging population are major factors expected to drive growth of the global nifedipine medication market during the forecast period.

Moreover, market players are indulged in launching new products for nifedipine and this is expected to increase the growth of the global nifedipine market, over the forecast period. For instance, on September 18, 2019, AVET Pharmaceuticals, a developer of generic medicines, launched nifedipine soft gel capsules. The products was being readily available in the potency of 10 and 20mg. This product is the AB-rated generic equivalent to the calcium blocker drug Procardia and adds to Avet's robust portfolio of generic oral solid products.

However, patent expiration, regulatory challenges, adverse effects, availability of alternative treatments, shifting treatment paradigms, pricing pressures are expected to hamper the growth of the global nifedipine medication market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global nifedipine medication market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nifedipine medication market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Johnson & Johnson, GlaxoSmithKline plc, Lupin Limited , Sun Pharmaceutical Industries Ltd., Sandoz International GmbH (a Novartis division) Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd, and Apotex
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global nifedipine medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nifedipine medication market

Global Nifedipine Medication Market Detailed Segmentation:

By Dosage Form:
- Tablets
- Extended-release Tablets
- Capsules
- Others (Sublingual tablets/spray, Patches and Others)
By Indication:
- Hypertension
- Angina Pectoris
- Raynaud's Phenomenon
- Others (Pre-term labor, vasospastic conditions and Others)
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sanofi S.A.
- Johnson & Johnson
- GlaxoSmithKline plc
- Lupin Limited
- Sun Pharmaceutical Industries Ltd.
- Sandoz International GmbH (a Novartis division)
- Dr. Reddy's Laboratories Ltd.
- Torrent Pharmaceuticals Ltd.
- Apotex Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Dosage Form
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Nifedipine Medication Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Nifedipine Medication Market, By Dosage Form, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Extended-Release Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Sublingual tablets/spray, Patches and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Nifedipine Medication Market, By Indication, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Angina Pectoris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Raynaud's Phenomenon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Pre-term labor, vasospastic conditions and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Nifedipine Medication Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. 8. Global Nifedipine Medication Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Sub-region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Sub-region, 2021 -2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profile
- Pfizer Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- AstraZeneca PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Teva Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Mylan N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Sanofi S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- GlaxoSmithKline plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Lupin Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Sandoz International GmbH (a Novartis division)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Dr. Reddy's Laboratories Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Torrent Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Apotex Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Analyst Views

10. Section

References
Research Methodology
About us

한글목차

시장 역학

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 니페디핀 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 니페디핀 시장 : 제형별, 2020-2032년

제6장 세계의 니페디핀 시장 : 적응증별, 2020-2032년

제7장 세계의 니페디핀 시장 : 유통 채널별, 2020-2032년

제8장 세계의 니페디핀 시장 : 지역별, 2020-2032년